Medicine
 |
|
19 february 2019 01:03:00 |
| Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome (Nature Medicine) |
|
Tweet |
| 63 viewsCategory: Medicine |
 Development of a CRISPR/Cas9-based therapy for Hutchinson-Gilford progeria syndrome (Nature Medicine)Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy (Nature Medicine) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
